1 Myotonic Dystrophy Therapeutics Market Overview 1.1 Product Overview and Scope of Myotonic Dystrophy Therapeutics 1.2 Myotonic Dystrophy Therapeutics Segment by Type 1.2.1 Global Myotonic Dystrophy Therapeutics Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Sodium Channel Blocker 1.2.3 Tricyclic Antidepressant 1.2.4 Other 1.3 Myotonic Dystrophy Therapeutics Segment by Application 1.3.1 Global Myotonic Dystrophy Therapeutics Sales Comparison by Application: (2021-2027) 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Other 1.4 Global Myotonic Dystrophy Therapeutics Market Size Estimates and Forecasts 1.4.1 Global Myotonic Dystrophy Therapeutics Revenue 2016-2027 1.4.2 Global Myotonic Dystrophy Therapeutics Sales 2016-2027 1.4.3 Myotonic Dystrophy Therapeutics Market Size by Region: 2016 Versus 2021 Versus 2027 2 Myotonic Dystrophy Therapeutics Market Competition by Manufacturers 2.1 Global Myotonic Dystrophy Therapeutics Sales Market Share by Manufacturers (2016-2021) 2.2 Global Myotonic Dystrophy Therapeutics Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Myotonic Dystrophy Therapeutics Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Myotonic Dystrophy Therapeutics Manufacturing Sites, Area Served, Product Type 2.5 Myotonic Dystrophy Therapeutics Market Competitive Situation and Trends 2.5.1 Myotonic Dystrophy Therapeutics Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Myotonic Dystrophy Therapeutics Players Market Share by Revenue 2.5.3 Global Myotonic Dystrophy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Myotonic Dystrophy Therapeutics Retrospective Market Scenario by Region 3.1 Global Myotonic Dystrophy Therapeutics Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Myotonic Dystrophy Therapeutics Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Myotonic Dystrophy Therapeutics Market Facts & Figures by Country 3.3.1 North America Myotonic Dystrophy Therapeutics Sales by Country 3.3.2 North America Myotonic Dystrophy Therapeutics Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Myotonic Dystrophy Therapeutics Market Facts & Figures by Country 3.4.1 Europe Myotonic Dystrophy Therapeutics Sales by Country 3.4.2 Europe Myotonic Dystrophy Therapeutics Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Myotonic Dystrophy Therapeutics Market Facts & Figures by Region 3.5.1 Asia Pacific Myotonic Dystrophy Therapeutics Sales by Region 3.5.2 Asia Pacific Myotonic Dystrophy Therapeutics Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Myotonic Dystrophy Therapeutics Market Facts & Figures by Country 3.6.1 Latin America Myotonic Dystrophy Therapeutics Sales by Country 3.6.2 Latin America Myotonic Dystrophy Therapeutics Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.6.6 Colombia 3.7 Middle East and Africa Myotonic Dystrophy Therapeutics Market Facts & Figures by Country 3.7.1 Middle East and Africa Myotonic Dystrophy Therapeutics Sales by Country 3.7.2 Middle East and Africa Myotonic Dystrophy Therapeutics Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Myotonic Dystrophy Therapeutics Historic Market Analysis by Type 4.1 Global Myotonic Dystrophy Therapeutics Sales Market Share by Type (2016-2021) 4.2 Global Myotonic Dystrophy Therapeutics Revenue Market Share by Type (2016-2021) 4.3 Global Myotonic Dystrophy Therapeutics Price by Type (2016-2021) 5 Global Myotonic Dystrophy Therapeutics Historic Market Analysis by Application 5.1 Global Myotonic Dystrophy Therapeutics Sales Market Share by Application (2016-2021) 5.2 Global Myotonic Dystrophy Therapeutics Revenue Market Share by Application (2016-2021) 5.3 Global Myotonic Dystrophy Therapeutics Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Lupin 6.1.1 Lupin Corporation Information 6.1.2 Lupin Description and Business Overview 6.1.3 Lupin Myotonic Dystrophy Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Lupin Myotonic Dystrophy Therapeutics Product Portfolio 6.1.5 Lupin Recent Developments/Updates 6.2 Teva 6.2.1 Teva Corporation Information 6.2.2 Teva Description and Business Overview 6.2.3 Teva Myotonic Dystrophy Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Teva Myotonic Dystrophy Therapeutics Product Portfolio 6.2.5 Teva Recent Developments/Updates 6.3 ANI Pharmaceuticals 6.3.1 ANI Pharmaceuticals Corporation Information 6.3.2 ANI Pharmaceuticals Description and Business Overview 6.3.3 ANI Pharmaceuticals Myotonic Dystrophy Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.3.4 ANI Pharmaceuticals Myotonic Dystrophy Therapeutics Product Portfolio 6.3.5 ANI Pharmaceuticals Recent Developments/Updates 6.4 Mylan 6.4.1 Mylan Corporation Information 6.4.2 Mylan Description and Business Overview 6.4.3 Mylan Myotonic Dystrophy Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Mylan Myotonic Dystrophy Therapeutics Product Portfolio 6.4.5 Mylan Recent Developments/Updates 6.5 Novartis 6.5.1 Novartis Corporation Information 6.5.2 Novartis Description and Business Overview 6.5.3 Novartis Myotonic Dystrophy Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Novartis Myotonic Dystrophy Therapeutics Product Portfolio 6.5.5 Novartis Recent Developments/Updates 6.6 Sun Pharma 6.6.1 Sun Pharma Corporation Information 6.6.2 Sun Pharma Description and Business Overview 6.6.3 Sun Pharma Myotonic Dystrophy Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Sun Pharma Myotonic Dystrophy Therapeutics Product Portfolio 6.6.5 Sun Pharma Recent Developments/Updates 6.7 Mallinckrodt 6.6.1 Mallinckrodt Corporation Information 6.6.2 Mallinckrodt Description and Business Overview 6.6.3 Mallinckrodt Myotonic Dystrophy Therapeutics Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Mallinckrodt Myotonic Dystrophy Therapeutics Product Portfolio 6.7.5 Mallinckrodt Recent Developments/Updates 7 Myotonic Dystrophy Therapeutics Manufacturing Cost Analysis 7.1 Myotonic Dystrophy Therapeutics Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Myotonic Dystrophy Therapeutics 7.4 Myotonic Dystrophy Therapeutics Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Myotonic Dystrophy Therapeutics Distributors List 8.3 Myotonic Dystrophy Therapeutics Customers 9 Myotonic Dystrophy Therapeutics Market Dynamics 9.1 Myotonic Dystrophy Therapeutics Industry Trends 9.2 Myotonic Dystrophy Therapeutics Growth Drivers 9.3 Myotonic Dystrophy Therapeutics Market Challenges 9.4 Myotonic Dystrophy Therapeutics Market Restraints 10 Global Market Forecast 10.1 Myotonic Dystrophy Therapeutics Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Myotonic Dystrophy Therapeutics by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Myotonic Dystrophy Therapeutics by Type (2022-2027) 10.2 Myotonic Dystrophy Therapeutics Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Myotonic Dystrophy Therapeutics by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Myotonic Dystrophy Therapeutics by Application (2022-2027) 10.3 Myotonic Dystrophy Therapeutics Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Myotonic Dystrophy Therapeutics by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Myotonic Dystrophy Therapeutics by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Myotonic Dystrophy Therapeutics Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Myotonic Dystrophy Therapeutics Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Myotonic Dystrophy Therapeutics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Myotonic Dystrophy Therapeutics Covered in This Study Table 5. Global Myotonic Dystrophy Therapeutics Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Myotonic Dystrophy Therapeutics Sales Market Share by Manufacturers (2016-2021) Table 7. Global Myotonic Dystrophy Therapeutics Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Myotonic Dystrophy Therapeutics Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Myotonic Dystrophy Therapeutics Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Myotonic Dystrophy Therapeutics Manufacturing Sites and Area Served Table 11. Manufacturers Myotonic Dystrophy Therapeutics Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Myotonic Dystrophy Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myotonic Dystrophy Therapeutics as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Myotonic Dystrophy Therapeutics Sales by Region (2016-2021) & (K Units) Table 16. Global Myotonic Dystrophy Therapeutics Sales Market Share by Region (2016-2021) Table 17. Global Myotonic Dystrophy Therapeutics Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Myotonic Dystrophy Therapeutics Sales by Country (2016-2021) & (K Units) Table 19. North America Myotonic Dystrophy Therapeutics Sales Market Share by Country (2016-2021) Table 20. North America Myotonic Dystrophy Therapeutics Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Myotonic Dystrophy Therapeutics Revenue Market Share by Country (2016-2021) Table 22. Europe Myotonic Dystrophy Therapeutics Sales by Country (2016-2021) & (K Units) Table 23. Europe Myotonic Dystrophy Therapeutics Sales Market Share by Country (2016-2021) Table 24. Europe Myotonic Dystrophy Therapeutics Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Myotonic Dystrophy Therapeutics Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Myotonic Dystrophy Therapeutics Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Myotonic Dystrophy Therapeutics Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Myotonic Dystrophy Therapeutics Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Myotonic Dystrophy Therapeutics Revenue Market Share by Region (2016-2021) Table 30. Latin America Myotonic Dystrophy Therapeutics Sales by Country (2016-2021) & (K Units) Table 31. Latin America Myotonic Dystrophy Therapeutics Sales Market Share by Country (2016-2021) Table 32. Latin America Myotonic Dystrophy Therapeutics Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Myotonic Dystrophy Therapeutics Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Myotonic Dystrophy Therapeutics Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Myotonic Dystrophy Therapeutics Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Myotonic Dystrophy Therapeutics Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Myotonic Dystrophy Therapeutics Revenue Market Share by Country (2016-2021) Table 38. Global Myotonic Dystrophy Therapeutics Sales (K Units) by Type (2016-2021) Table 39. Global Myotonic Dystrophy Therapeutics Sales Market Share by Type (2016-2021) Table 40. Global Myotonic Dystrophy Therapeutics Revenue (Million US$) by Type (2016-2021) Table 41. Global Myotonic Dystrophy Therapeutics Revenue Share by Type (2016-2021) Table 42. Global Myotonic Dystrophy Therapeutics Price (US$/Unit) by Type (2016-2021) Table 43. Global Myotonic Dystrophy Therapeutics Sales (K Units) by Application (2016-2021) Table 44. Global Myotonic Dystrophy Therapeutics Sales Market Share by Application (2016-2021) Table 45. Global Myotonic Dystrophy Therapeutics Revenue (Million US$) by Application (2016-2021) Table 46. Global Myotonic Dystrophy Therapeutics Revenue Share by Application (2016-2021) Table 47. Global Myotonic Dystrophy Therapeutics Price (US$/Unit) by Application (2016-2021) Table 48. Lupin Corporation Information Table 49. Lupin Description and Business Overview Table 50. Lupin Myotonic Dystrophy Therapeutics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. Lupin Myotonic Dystrophy Therapeutics Product Table 52. Lupin Recent Developments/Updates Table 53. Teva Corporation Information Table 54. Teva Description and Business Overview Table 55. Teva Myotonic Dystrophy Therapeutics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Teva Myotonic Dystrophy Therapeutics Product Table 57. Teva Recent Developments/Updates Table 58. ANI Pharmaceuticals Corporation Information Table 59. ANI Pharmaceuticals Description and Business Overview Table 60. ANI Pharmaceuticals Myotonic Dystrophy Therapeutics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. ANI Pharmaceuticals Myotonic Dystrophy Therapeutics Product Table 62. ANI Pharmaceuticals Recent Developments/Updates Table 63. Mylan Corporation Information Table 64. Mylan Description and Business Overview Table 65. Mylan Myotonic Dystrophy Therapeutics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. Mylan Myotonic Dystrophy Therapeutics Product Table 67. Mylan Recent Developments/Updates Table 68. Novartis Corporation Information Table 69. Novartis Description and Business Overview Table 70. Novartis Myotonic Dystrophy Therapeutics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 71. Novartis Myotonic Dystrophy Therapeutics Product Table 72. Novartis Recent Developments/Updates Table 73. Sun Pharma Corporation Information Table 74. Sun Pharma Description and Business Overview Table 75. Sun Pharma Myotonic Dystrophy Therapeutics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 76. Sun Pharma Myotonic Dystrophy Therapeutics Product Table 77. Sun Pharma Recent Developments/Updates Table 78. Mallinckrodt Corporation Information Table 79. Mallinckrodt Description and Business Overview Table 80. Mallinckrodt Myotonic Dystrophy Therapeutics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 81. Mallinckrodt Myotonic Dystrophy Therapeutics Product Table 82. Mallinckrodt Recent Developments/Updates Table 83. Production Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Myotonic Dystrophy Therapeutics Distributors List Table 86. Myotonic Dystrophy Therapeutics Customers List Table 87. Myotonic Dystrophy Therapeutics Market Trends Table 88. Myotonic Dystrophy Therapeutics Growth Drivers Table 89. Myotonic Dystrophy Therapeutics Market Challenges Table 90. Myotonic Dystrophy Therapeutics Market Restraints Table 91. Global Myotonic Dystrophy Therapeutics Sales Forecast by Type (2022-2027) & (K Units) Table 92. Global Myotonic Dystrophy Therapeutics Sales Market Share Forecast by Type (2022-2027) Table 93. Global Myotonic Dystrophy Therapeutics Revenue Forecast by Type (2022-2027) & (US$ Million) Table 94. Global Myotonic Dystrophy Therapeutics Revenue Market Share Forecast by Type (2022-2027) Table 95. Global Myotonic Dystrophy Therapeutics Sales Forecast by Application (2022-2027) & (K Units) Table 96. Global Myotonic Dystrophy Therapeutics Sales Market Share Forecast by Application (2022-2027) Table 97. Global Myotonic Dystrophy Therapeutics Revenue Forecast by Application (2022-2027) & (US$ Million) Table 98. Global Myotonic Dystrophy Therapeutics Revenue Market Share Forecast by Application (2022-2027) Table 99. Global Myotonic Dystrophy Therapeutics Sales Forecast by Region (2022-2027) & (K Units) Table 100. Global Myotonic Dystrophy Therapeutics Sales Market Share Forecast by Region (2022-2027) Table 101. Global Myotonic Dystrophy Therapeutics Revenue Forecast by Region (2022-2027) & (US$ Million) Table 102. Global Myotonic Dystrophy Therapeutics Revenue Market Share Forecast by Region (2022-2027) Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Myotonic Dystrophy Therapeutics Figure 2. Global Myotonic Dystrophy Therapeutics Market Share by Type in 2020 & 2027 Figure 3. Sodium Channel Blocker Product Picture Figure 4. Tricyclic Antidepressant Product Picture Figure 5. Other Product Picture Figure 6. Global Myotonic Dystrophy Therapeutics Market Share by Application in 2020 & 2027 Figure 7. Hospital Pharmacy Figure 8. Retail Pharmacy Figure 9. Other Figure 10. Global Myotonic Dystrophy Therapeutics Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Myotonic Dystrophy Therapeutics Market Size 2016-2027 (US$ Million) Figure 12. Global Myotonic Dystrophy Therapeutics Sales 2016-2027 (K Units) Figure 13. Global Myotonic Dystrophy Therapeutics Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Myotonic Dystrophy Therapeutics Sales Share by Manufacturers in 2020 Figure 15. Global Myotonic Dystrophy Therapeutics Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Myotonic Dystrophy Therapeutics Players: Market Share by Revenue in 2020 Figure 17. Myotonic Dystrophy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Myotonic Dystrophy Therapeutics Sales Market Share by Region (2016-2021) Figure 19. Global Myotonic Dystrophy Therapeutics Sales Market Share by Region in 2020 Figure 20. Global Myotonic Dystrophy Therapeutics Revenue Market Share by Region (2016-2021) Figure 21. Global Myotonic Dystrophy Therapeutics Revenue Market Share by Region in 2020 Figure 22. United States Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. China Taiwan Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Mexico Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Brazil Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Argentina Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Colombia Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. UAE Myotonic Dystrophy Therapeutics Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Myotonic Dystrophy Therapeutics by Type (2016-2021) Figure 46. Sales Market Share of Myotonic Dystrophy Therapeutics by Application (2016-2021) Figure 47. Sales Market Share of Myotonic Dystrophy Therapeutics by Application in 2020 Figure 48. Revenue Share of Myotonic Dystrophy Therapeutics by Application (2016-2021) Figure 49. Revenue Share of Myotonic Dystrophy Therapeutics by Application in 2020 Figure 50. Manufacturing Cost Structure of Myotonic Dystrophy Therapeutics Figure 51. Manufacturing Process Analysis of Myotonic Dystrophy Therapeutics Figure 52. Myotonic Dystrophy Therapeutics Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Lupin Teva ANI Pharmaceuticals Mylan Novartis Sun Pharma Mallinckrodt